SEC Form 4 · accession 0001209191-16-147727

HCA Healthcare, Inc. · HCA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

P. Martin Paslick

Officer — SVP and CIO

Period of report

Oct 28, 2016

Accepted (ET)

Nov 1, 2016 · 7:23 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000860730

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Oct 28, 2016	M	9,002	$5.3074	A	35,894	D
Common Stock	Oct 28, 2016	M	27,002	$11.3208	A	62,896	D
Common Stock^F1	Oct 28, 2016	S	36,004	$78.7942	D	26,892	D
Common Stock^F2	holding	—	—		—	138	I	By Son

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Non-Qualified Stock Option (right to buy)^F3,F4,F5	$5.3074	Oct 28, 2016	M	9,002	D	—	Jan 30, 2017	Common Stock	9,002	D
Non-Qualified Stock Option (right to buy)^F3,F6,F5	$11.3208	Oct 28, 2016	M	13,501	D	—	Jan 30, 2017	Common Stock	13,501	D
Non-Qualified Stock Option (right to buy)^F3,F7,F5	$11.3208	Oct 28, 2016	M	13,501	D	—	Jan 30, 2017	Common Stock	13,501	D

Explanation of responses

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.62 to $78.99, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2Includes 28.207 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan
F3Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
F4On January 30, 2007, the reporting person was granted an option to purchase 22,502 shares of common stock, which vest upon achievement of certain predetermined investment return targets. 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of the closing of the initial public offering of the Issuer's securities on March 15, 2011, 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2011 and 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2012.
F5Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
F6The option vested in three equal annual installments beginning on January 30, 2008.
F7The option vested in equal increments at the end of fiscal years 2007, 2008 and 2009 based upon the achievement of certain annual EBITDA performance targets.